强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JNJ 强生

未开盘 06-16 16:00:00 EDT

235.18

-0.48

-0.20%

盘后234.00

-1.18-0.50%

19:59 EDT

最高236.37	最低231.02	成交量771.81万
今开236.37	昨收235.66	日振幅2.27%
总市值5,666亿	流通市值5,655亿	总股本24.09亿
成交额18.10亿	换手率0.32%	流通股本24.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":235.18,"timestamp":1781640000000,"preClose":235.66,"halted":0,"volume":7718141,"hourTrading":{"tag":"盘后","latestPrice":234,"preClose":235.18,"latestTime":"19:59 EDT","volume":1320517,"amount":310546048.6073,"timestamp":1781654390975,"change":-1.18,"changeRate":-0.005017,"amplitude":0.005017},"delay":0,"changeRate":-0.002036832725112407,"floatShares":2404573193,"shares":2409295102,"eps":8.635366,"marketStatus":"未开盘","change":-0.48,"latestTime":"06-16 16:00:00 EDT","open":236.37,"high":236.37,"low":231.02,"amount":1809871802.67062,"amplitude":0.022702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.635366,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781683200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":235.66,"dividendRate":0.022111,"preHourTrading":{"tag":"盘前","latestPrice":237.46,"preClose":235.66,"latestTime":"09:29 EDT","volume":155459,"amount":36637307.01997,"timestamp":1781616565416,"change":1.8,"changeRate":0.007638,"amplitude":0.014067},"postHourTrading":{"tag":"盘后","latestPrice":234,"preClose":235.18,"latestTime":"19:59 EDT","volume":1320517,"amount":310546048.6073,"timestamp":1781654390975,"change":-1.18,"changeRate":-0.005017,"amplitude":0.005017},"volumeRatio":1.007705,"impliedVol":0.2651,"impliedVolPercentile":0.8287},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"1162854079","title":"异动解读｜强生盘中下跌3.02%，报237.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162854079","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162854079?lang=zh_cn&edition=full","pubTime":"2026-06-15 22:59","pubTimestamp":1781535577,"startTime":"0","endTime":"0","summary":"6月15日，强生盘中下跌3.02%，报237.32美元/股，成交额3.85亿美元。强生所在的制药行业中，个股表现分化，其中礼来涨0.09%，默沙东跌1.7%，辉瑞涨0.55%，诺和诺德涨1.31%，施贵宝跌1.23%。强生跌幅明显大于同业，表现显著弱于板块整体水平。强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业，通过创新药物和医疗技术两个主要业务部门运营，专注于研究、开发、制造、销售种类丰富的医疗保健产品。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176248398","title":"Talvey®联合Darzalex Faspro®新数据彰显双特异性组合疗法在早期复发或难治性多发性骨髓瘤中的优势","url":"https://stock-news.laohu8.com/highlight/detail?id=1176248398","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176248398?lang=zh_cn&edition=full","pubTime":"2026-06-13 18:35","pubTimestamp":1781346915,"startTime":"0","endTime":"0","summary":"最新公布的Talvey®（Talquetamab-Tgvs）联合Darzalex Faspro®（达雷妥尤单抗与透明质酸酶-fihj）研究数据，有力证实了这种双特异性抗体组合方案在治疗早期复发或难治性多发性骨髓瘤患者中的显著疗效与临床价值。该结果凸显了这一创新联合疗法在提升治疗深度与持久性方面的潜力，为多发性骨髓瘤的治疗格局带来了新的希望。研究数据显示，联合疗法在关键疗效指标上表现出积极且稳健的结果，进一步支持了其在临床实践中的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689514.USD","SG9999002232.USD","LU2112291526.USD","LU1585245621.USD","BK4007","LU2471134796.USD","LU2602419157.SGD","LU0234572021.USD","LU1162221912.USD","LU0114720955.EUR","LU1778281490.HKD","IE00BBT3K403.USD","LU1935042991.SGD","LU1894683348.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0964807845.USD","LU0345769128.USD","BK4550","LU2505996509.AUD","LU0289739699.SGD","IE000SO60NU8.SGD","LU0234570918.USD","LU0432979614.USD","LU1674673428.USD","LU0820561909.HKD","LU2430703095.HKD","LU0058720904.USD","BK4585","LU2750360641.GBP","SG9999002224.SGD","JNJ","LU1228905037.USD","IE0034235303.USD","LU2023250330.USD","IE00BLSP4452.SGD","IE00B42XCP33.USD","LU1496350502.SGD","LU1145028129.USD","LU0122379950.USD","BK4588","LU1551013342.USD","LU2129689605.HKD","LU1059921491.USD","IE00BSNM7G36.USD","LU0345769631.USD","LU1914381329.SGD","LU0203345920.USD","IE00B2B36J28.USD","SG9999001440.SGD","IE00BGHQF631.EUR","LU2347655156.SGD","LU2896262040.SGD","SG9999013999.USD","LU1221951129.SGD","LU2430703178.SGD","LU0124676726.USD","LU0345770308.USD","LU1929549753.HKD","LU1732799900.SGD","LU2213496289.HKD","IE00B4R5TH58.HKD","LU2430703251.USD","IE00BFTCPJ56.SGD","LU2592432038.USD","LU2417539215.USD","LU2456880835.USD","IE0002270589.USD","LU1023059063.AUD","LU1121112475.USD","IE000MB6IJN5.SGD","IE00BDGV0183.EUR","LU0689472784.USD","LU1430594728.SGD","LU1732800096.USD","LU0792757196.USD","BK4532","BK4534","LU1674673691.USD","LU0210528500.USD","LU1057294990.SGD","LU2403377893.USD","IE0000B7K699.USD","IE00B7SZLL34.SGD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU2750360997.AUD","LU1629891620.HKD","IE00B3T34201.USD","LU1032466523.USD","LU1244550221.USD","LU0689626769.HKD","LU0994945656.USD","IE00BVYPNW00.USD","IE000F7OJYX1.SGD","LU0683600562.USD","LU1894683264.USD","LU0882574055.USD","LU0053666078.USD","LU0795875169.SGD","IE000BZT7R73.USD","LU2471134879.HKD","LU2089984988.USD","LU0820561818.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","LU1506573853.SGD","IE00BJT1NW94.SGD","LU0795875086.SGD","LU2756315318.SGD","LU1267930813.SGD","IE000M9KFDE8.USD","LU1718418525.SGD","LU0985320562.USD","LU1280957306.USD","LU2471134523.USD","LU0098860793.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE0002141913.USD","LU1244550577.SGD","LU0426412945.USD","LU1261432733.SGD","LU2236285917.USD","IE00BZ1G4Q59.USD","LU2471134952.CNY","LU0787776722.HKD","LU0203347892.USD","LU1061106388.HKD","SG9999001176.USD","LU0426417589.USD","LU0820562030.AUD","LU1983299246.USD","LU2468319806.SGD","LU2487616109.SGD","LU0889566641.SGD","LU1228905540.USD","LU1043141123.HKD","LU1244550494.USD","LU0210536198.USD","BK4568","IE00BN8TJ469.HKD","LU1221951046.USD","BK4533","LU0912757837.SGD","BK4559","LU0070217475.USD","LU1066053197.SGD","IE00B3PB1722.GBP","LU1551013425.SGD","LU1074936037.SGD","LU0345770993.USD","BK4504","IE0009355771.USD","LU2129689431.USD","LU1032955483.USD","LU1196500208.SGD","IE000WAW04H5.SGD","LU1066051498.USD","LU1066051811.HKD","LU1043141396.HKD","BK4581","BK4592","LU1066051225.USD","LU0545562505.USD","IE00B19Z3581.USD","LU0640476718.USD","IE00BFXG1179.USD","LU2133065610.SGD","LU2756315664.SGD","SG9999001176.SGD","LU0943347566.SGD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642528047","title":"强生在美国全面推广TECNIS PureSee人工晶状体，为白内障手术提供更优选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2642528047","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642528047?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:15","pubTimestamp":1781187300,"startTime":"0","endTime":"0","summary":"强生公司本周宣布，其研发的TECNIS PureSee人工晶状体正式在美国全面上市。　　TECNIS PureSee人工晶状体是首款获得美国食品药品监督管理局批准的扩展焦深人工晶状体，且无需在标签上标注对比敏感度下降的警告。　　强生公司外科视觉北美区总裁表示，随着TECNIS PureSee人工晶状体在美国全面上市，他们正在为更多患者提供这一重要的扩展焦深视力解决方案，患者希望获得能够支持其日常生活的视力方案。目前，全球已有超过50万只眼睛植入了TECNIS PureSee人工晶状体。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-11/doc-inicaene5368536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0210528500.USD","LU1629891620.HKD","LU1066051225.USD","LU1074936037.SGD","LU1145028129.USD","IE00BKVL7J92.USD","LU0058720904.USD","SG9999002232.USD","LU0210536198.USD","LU2756315664.SGD","LU2129689431.USD","LU2213496289.HKD","LU2756315318.SGD","JNJ","LU1059921491.USD","SG9999001176.SGD","IE00BLSP4239.USD","LU1674673691.USD","IE000WAW04H5.SGD","LU1496350502.SGD","LU1935042991.SGD","LU1244550221.USD","LU2471134523.USD","LU0070217475.USD","LU1674673428.USD","LU2089984988.USD","LU2112291526.USD","LU2129689605.HKD","LU1280957306.USD","LU2505996509.AUD","IE0001KFT4U8.USD","LU1894683348.USD","LU1066051811.HKD","SGXZ57979304.SGD","LU0882574055.USD","IE0002141913.USD","LU2430703251.USD","SG9999001176.USD","LU1061106388.HKD","BK4585","LU1983299246.USD","LU1228905540.USD","IE00B4R5TH58.HKD","LU1196500208.SGD","LU2129689514.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","LU0792757196.USD","LU0640476718.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642820842","title":"强生(JNJ)宣布扩大其全新老花矫正人工晶体在美国市场供应范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2642820842","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642820842?lang=zh_cn&edition=full","pubTime":"2026-06-11 21:08","pubTimestamp":1781183310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生公司(JNJ)旗下眼科手术业务部宣布，将正式扩大其最新一代老花眼矫正人工晶状体(PC-IOL)——TECNIS PureSee在全美市场的商业化供应范围。目前，该产品在全球已累计完成超过50万例临床植入，患者满意度及推荐率高达97%。据悉，该晶体是全美首款、也是唯一一款获得美国食品药品监督管理局(FDA)批准、且未被附加“对比敏感度降低”警告的连续景深(EDOF)人工晶状体。强生该新晶体实现了与单焦点晶体相媲美的视觉清晰度。临床数据显示，该晶体能为白内障及老花眼患者提供卓越的远距离、中距离视力以及部分近距离视力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301452","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","IE00B7SZLL34.SGD","IE000SO60NU8.SGD","IE00BFXG1179.USD","LU2602419157.SGD","LU0820561909.HKD","LU1430594728.SGD","LU0466842654.USD","LU0912757837.SGD","LU0943347566.SGD","BK4533","LU2023250330.USD","SG9999001176.USD","SG9999002224.SGD","IE00BVYPNW00.USD","LU0792757196.USD","LU1585245621.USD","IE00B3T34201.USD","IE00B2B36J28.USD","BK4581","LU2430703095.HKD","IE00B4R5TH58.HKD","LU0234572021.USD","SG9999013999.USD","LU0124676726.USD","LU1023059063.AUD","LU2112291526.USD","LU1228905540.USD","LU1121112475.USD","LU0426412945.USD","JNJ","LU1674673428.USD","LU0320765646.SGD","IE0000B7K699.USD","LU0426417589.USD","LU2750360997.AUD","LU2505996681.GBP","LU0234570918.USD","LU1066051498.USD","IE00B19Z3581.USD","LU2471134523.USD","LU0545562505.USD","LU1551013425.SGD","IE0002270589.USD","LU0345770308.USD","LU0985320562.USD","LU1261432733.SGD","LU1674673691.USD","LU2089984988.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188867942","title":"强生扩大Tecnis PureSee人工晶状体在美国市场供应，为白内障医患提供先进选择","url":"https://stock-news.laohu8.com/highlight/detail?id=1188867942","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188867942?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:46","pubTimestamp":1781178384,"startTime":"0","endTime":"0","summary":"强生公司宣布，将扩大其先进人工晶状体产品Tecnis PureSee在美国市场的可及性。此举旨在为白内障手术医生及患者提供一项创新的视力矫正解决方案。\nTecnis PureSee是一款专为白内障患者设计的高端人工晶状体。其技术特点在于能够为患者提供更广泛的视程范围，并有望减少术后对眼镜的依赖。该产品的推广，反映了强生在眼科医疗设备领域持续创新的战略布局。\n通过提升该产品在美国的供应能力，强生期望满足日益增长的市场需求，并为白内障手术患者带来更优质的视觉结果和生活质量改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU1061106388.HKD","LU2403377893.USD","LU2592432038.USD","LU1228905540.USD","LU1983299246.USD","LU1914381329.SGD","BK4568","LU2213496289.HKD","LU2430703251.USD","LU0432979614.USD","LU2129689605.HKD","SG9999001440.SGD","LU2756315664.SGD","IE00B7SZLL34.SGD","LU2456880835.USD","LU1145028129.USD","LU1629891620.HKD","LU1674673428.USD","IE000M9KFDE8.USD","LU2430703095.HKD","JNJ","LU1496350502.SGD","LU2133065610.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0964807845.USD","LU0098860793.USD","BK4532","LU0689626769.HKD","LU0820561818.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1244550494.USD","LU1196500208.SGD","LU0889566641.SGD","SG9999001176.SGD","SG9999001176.USD","BK4550","LU0053666078.USD","LU0345770993.USD","IE00B42XCP33.USD","LU0689472784.USD","LU1228905037.USD","LU1221951046.USD","LU2347655156.SGD","LU1059921491.USD","LU1506573853.SGD","LU0426417589.USD","LU1066053197.SGD","LU0320765646.SGD","IE0000B7K699.USD","BK4585","IE00B3PB1722.GBP","IE00BFTCPJ56.SGD","LU1066051498.USD","LU2505996509.AUD","LU2505996681.GBP","LU0210528500.USD","LU1066051225.USD","LU1929549753.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU0795875169.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0058720904.USD","LU2471134952.CNY","LU2750360997.AUD","LU0345769631.USD","LU1894683348.USD","BK4533","BK4581","IE00BLSP4239.USD","LU1244550221.USD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU1935042991.SGD","IE00BVYPNW00.USD","LU1066051811.HKD","LU1032466523.USD","LU2471134523.USD","LU0787776722.HKD","IE000MB6IJN5.SGD","SG9999002224.SGD","IE00BGHQF631.EUR","LU2430703178.SGD","BK4559","IE0002270589.USD","LU0545562505.USD","LU1032955483.USD","IE00BN8TJ469.HKD","LU0795875086.SGD","LU1221951129.SGD","IE00B4R5TH58.HKD","LU1280957306.USD","IE00BFXG1179.USD","LU2471134879.HKD","LU0994945656.USD","LU1674673691.USD","IE00B3T34201.USD","LU1732799900.SGD","IE00B1BXHZ80.USD","LU1585245621.USD","LU2129689514.USD","IE000BZT7R73.USD","LU0426412945.USD","LU2750360641.GBP","BK4007","IE0009355771.USD","LU1043141396.HKD","IE000F7OJYX1.SGD","LU1267930813.SGD","LU0122379950.USD","LU0683600562.USD","LU2129689431.USD","LU1551013342.USD","IE00BKVL7J92.USD","LU1261432733.SGD","LU1894683264.USD","LU1718418525.SGD","LU0210536198.USD","LU1121112475.USD","BK4504","LU2896262040.SGD","LU2236285917.USD","SGXZ57979304.SGD","LU0124676726.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU0070217475.USD","SG9999013999.USD","LU2471134796.USD","LU0345770308.USD","LU0640476718.USD","IE00BVYPNV92.GBP","LU0289739699.SGD","LU1244550577.SGD","LU2023250330.USD","IE0001KFT4U8.USD","LU1732800096.USD","LU0466842654.USD","LU0234570918.USD","LU0943347566.SGD","LU1778281490.HKD","LU1074936037.SGD","LU1162221912.USD","LU0912757837.SGD","SG9999002232.USD","LU1043141123.HKD","LU0820562030.AUD","LU0792757196.USD","LU2089984988.USD","LU0882574055.USD","IE000WAW04H5.SGD","IE0034235303.USD","LU0203347892.USD","LU0985320562.USD","IE0002141913.USD","IE000SO60NU8.SGD","LU2602419157.SGD","LU0345769128.USD","LU0203345920.USD","LU0820561909.HKD","LU1551013425.SGD","LU2756315318.SGD","BK4534","LU2417539215.USD","BK4588","LU2112291526.USD","BK4592","IE00BBT3K403.USD","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169109346","title":"Imaavy® (Nipocalimab-Aahu)在关键性2/3期研究中展现持久血红蛋白应答与快速起效，针对尚无FDA批准疗法的温抗体型自身免疫性溶血性贫血","url":"https://stock-news.laohu8.com/highlight/detail?id=1169109346","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169109346?lang=zh_cn&edition=full","pubTime":"2026-06-11 14:04","pubTimestamp":1781157857,"startTime":"0","endTime":"0","summary":"Imaavy® (Nipocalimab-Aahu)在一项针对温抗体型自身免疫性溶血性贫血的关键性2/3期研究中，展现出持久的血红蛋白应答与快速的起效速度。温抗体型自身免疫性溶血性贫血是一种由自身抗体驱动的疾病，目前尚无任何疗法获得美国食品药品监督管理局的批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0426412945.USD","LU1894683264.USD","IE000WAW04H5.SGD","IE00B4R5TH58.HKD","LU2505996509.AUD","LU2602419157.SGD","LU1914381329.SGD","LU1585245621.USD","LU2089984988.USD","LU0053666078.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU0070217475.USD","IE00B42XCP33.USD","LU1057294990.SGD","BK4581","LU1732800096.USD","LU2487616109.SGD","LU2129689514.USD","LU2756315318.SGD","LU0124676726.USD","IE00BVYPNV92.GBP","IE00B19Z3581.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU0466842654.USD","LU0795875169.SGD","LU2129689605.HKD","LU2456880835.USD","LU0882574055.USD","BK4585","LU1244550494.USD","BK4007","LU1674673691.USD","LU2471134879.HKD","IE00BVYPNW00.USD","LU1267930813.SGD","LU1121112475.USD","IE00BLSP4452.SGD","LU1043141123.HKD","LU0689472784.USD","LU1244550221.USD","LU1506573853.SGD","LU2023250330.USD","LU1043141396.HKD","LU1032466523.USD","LU1059921491.USD","BK4534","IE00BJT1NW94.SGD","LU0795875086.SGD","LU1261432733.SGD","LU1894683348.USD","LU2896262040.SGD","LU0345769128.USD","LU1023059063.AUD","LU2430703178.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0432979614.USD","LU0320765646.SGD","BK4588","LU1074936037.SGD","IE00BFXG1179.USD","LU0345770993.USD","LU1732799900.SGD","LU0994945656.USD","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU1228905540.USD","LU0234572021.USD","LU1935042991.SGD","LU1221951046.USD","LU0985320562.USD","BK4550","BK4504","LU1221951129.SGD","SG9999002232.USD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0345770308.USD","LU2403377893.USD","LU0943347566.SGD","IE00BLSP4239.USD","LU0689626769.HKD","LU2471134796.USD","LU2213496289.HKD","LU2129689431.USD","SG9999001176.USD","LU2468319806.SGD","LU1066051811.HKD","LU2112291526.USD","LU0683600562.USD","LU0426417589.USD","IE0001KFT4U8.USD","IE00B7SZLL34.SGD","LU0345769631.USD","IE000F7OJYX1.SGD","LU1244550577.SGD","IE0000B7K699.USD","IE0034235303.USD","LU0820562030.AUD","LU2750360997.AUD","LU2236285917.USD","LU0640476718.USD","LU1145028129.USD","JNJ","LU1061106388.HKD","LU1629891620.HKD","SG9999013999.USD","LU0210528500.USD","LU2471134952.CNY","IE00B19Z3B42.SGD","LU0820561818.USD","LU2133065610.SGD","BK4559","BK4592","BK4568","LU0210536198.USD","LU1280957306.USD","LU1674673428.USD","LU1162221912.USD","SG9999002224.SGD","LU1983299246.USD","IE000SO60NU8.SGD","LU1430594728.SGD","LU2505996681.GBP","LU1496350502.SGD","LU2430703095.HKD","IE000BZT7R73.USD","LU0114720955.EUR","LU0912757837.SGD","IE00BDGV0183.EUR","LU2471134523.USD","LU0787776722.HKD","LU0964807845.USD","LU2756315664.SGD","LU0058720904.USD","LU1066051225.USD","LU0203345920.USD","LU0203347892.USD","LU0889566641.SGD","LU1228905037.USD","LU1551013425.SGD","LU0545562505.USD","BK4533","IE00B3T34201.USD","BK4532","LU1718418525.SGD","LU1551013342.USD","SG9999001176.SGD","LU1778281490.HKD","LU0820561909.HKD","LU1032955483.USD","IE0009355771.USD","LU2592432038.USD","LU2417539215.USD","SG9999001440.SGD","IE000MB6IJN5.SGD","LU1196500208.SGD","LU0792757196.USD","IE00B3PB1722.GBP","LU0289739699.SGD","LU2347655156.SGD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU2430703251.USD","IE00BSNM7G36.USD","IE00BBT3K403.USD","IE00BFTCPJ56.SGD","LU1066051498.USD","LU0098860793.USD","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109191646","title":"强生高管称银屑病口服药Icotyde现有约4500名处方医生 直接面向消费者营销活动预计即将启动——高盛医疗健康大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1109191646","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109191646?lang=zh_cn&edition=full","pubTime":"2026-06-09 22:49","pubTimestamp":1781016562,"startTime":"0","endTime":"0","summary":"强生公司高管在高盛医疗健康大会上透露，其银屑病口服药物Icotyde目前已有约4500名医生开具处方。此外，针对该药物的直接面向消费者的营销活动预计将在近期启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","LU0070217475.USD","LU1043141123.HKD","LU2129689431.USD","LU1267930813.SGD","LU1430594728.SGD","IE00BBT3K403.USD","IE0001KFT4U8.USD","LU1718418525.SGD","IE00B3T34201.USD","LU1506573853.SGD","LU1551013342.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU2430703095.HKD","SG9999001176.USD","BK4504","LU2133065610.SGD","IE00B3PB1722.GBP","IE00B7SZLL34.SGD","LU1057294990.SGD","LU2505996681.GBP","BK4585","IE00B1BXHZ80.USD","LU1059921491.USD","LU0820562030.AUD","LU2471134879.HKD","LU2756315318.SGD","LU0289739699.SGD","LU2347655156.SGD","IE00B2B36J28.USD","IE000SO60NU8.SGD","LU1023059063.AUD","LU1894683348.USD","IE00BLSP4452.SGD","LU1629891620.HKD","LU2487616109.SGD","IE0002141913.USD","LU1032466523.USD","LU1061106388.HKD","LU0889566641.SGD","LU2750360997.AUD","LU1778281490.HKD","LU1032955483.USD","LU2403377893.USD","IE0009355771.USD","LU1121112475.USD","LU0426417589.USD","LU2430703178.SGD","LU2471134523.USD","SG9999002224.SGD","LU0912757837.SGD","LU0683600562.USD","BK4534","LU0426412945.USD","LU2750360641.GBP","LU0943347566.SGD","LU2756315664.SGD","LU2896262040.SGD","LU1929549753.HKD","LU2213496289.HKD","LU2505996509.AUD","IE00BFTCPJ56.SGD","BK4550","LU0098860793.USD","LU1914381329.SGD","IE00BGHQF631.EUR","IE000BZT7R73.USD","LU1496350502.SGD","BK4592","IE00B19Z3B42.SGD","LU1145028129.USD","LU0787776722.HKD","LU1066051498.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU1244550221.USD","LU0203345920.USD","LU1196500208.SGD","LU0234570918.USD","LU2592432038.USD","LU1732799900.SGD","LU1221951046.USD","LU0689472784.USD","LU0210536198.USD","IE00BVYPNW00.USD","SG9999002232.USD","IE00BFXG1179.USD","LU0320765646.SGD","LU1261432733.SGD","LU0820561909.HKD","LU0210528500.USD","BK4568","BK4533","LU0795875086.SGD","BK4532","IE00BJJMRZ35.SGD","LU0124676726.USD","LU2129689514.USD","LU0345769128.USD","LU2417539215.USD","LU0545562505.USD","BK4559","LU1221951129.SGD","LU2471134796.USD","IE00B19Z3581.USD","LU0345769631.USD","LU1228905540.USD","LU2456880835.USD","BK4581","LU1674673428.USD","IE00B42XCP33.USD","LU0985320562.USD","LU0640476718.USD","LU1043141396.HKD","IE000WAW04H5.SGD","SG9999001440.SGD","LU0689626769.HKD","LU2471134952.CNY","LU2468319806.SGD","LU0345770993.USD","LU0882574055.USD","IE00BLSP4239.USD","LU0058720904.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0964807845.USD","LU1066051225.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU0053666078.USD","IE00BSNM7G36.USD","BK4588","LU0466842654.USD","IE0002270589.USD","LU0792757196.USD","LU0203347892.USD","LU1732800096.USD","LU1228905037.USD","IE0034235303.USD","IE000F7OJYX1.SGD","LU1244550494.USD","LU0345770308.USD","LU1162221912.USD","LU1074936037.SGD","IE00BVYPNV92.GBP","LU0122379950.USD","LU0795875169.SGD","LU0114720955.EUR","LU2129689605.HKD","LU1674673691.USD","LU2089984988.USD","BK4007","LU0432979614.USD","LU2430703251.USD","LU2112291526.USD","LU1935042991.SGD","LU2602419157.SGD","IE00BN8TJ469.HKD","LU0994945656.USD","LU1066051811.HKD","LU1983299246.USD","LU2023250330.USD","SG9999001176.SGD","IE000MB6IJN5.SGD","LU0234572021.USD","LU1585245621.USD","LU0820561818.USD","LU2236285917.USD","JNJ","LU1894683264.USD","SG9999013999.USD","IE00BDGV0183.EUR","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178922449","title":"英国MHRA授权尼泊卡单抗（商品名：Imaavy）用于治疗成人和12岁及以上青少年全身型重症肌无力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178922449","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178922449?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:29","pubTimestamp":1781008161,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局（MHRA）已批准新药尼泊卡单抗（商品名：Imaavy）上市，用于治疗成人和12岁及以上青少年患者的全身型重症肌无力。该药物由强生公司研发，旨在为这一罕见自身免疫性神经系统疾病提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU2471134796.USD","IE000F7OJYX1.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1196500208.SGD","LU1496350502.SGD","LU1261432733.SGD","LU1585245621.USD","LU1228905540.USD","SG9999001440.SGD","LU1057294990.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0889566641.SGD","LU1043141396.HKD","SG9999013999.USD","LU2236285917.USD","LU2347655156.SGD","LU0426417589.USD","LU2213496289.HKD","BK4532","LU0124676726.USD","IE00B2B36J28.USD","LU0683600562.USD","BK4550","LU0820561818.USD","LU0432979614.USD","IE000SO60NU8.SGD","LU2133065610.SGD","LU0053666078.USD","BK4504","LU1066051225.USD","LU0792757196.USD","SG9999002224.SGD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU2430703178.SGD","LU2471134879.HKD","LU2750360641.GBP","BK4559","LU0912757837.SGD","LU1983299246.USD","LU1032466523.USD","LU2468319806.SGD","LU0210528500.USD","LU1066051498.USD","IE00B3T34201.USD","LU1121112475.USD","LU2505996509.AUD","LU1551013425.SGD","IE000BZT7R73.USD","LU2023250330.USD","LU0820561909.HKD","LU1267930813.SGD","LU0964807845.USD","LU1551013342.USD","LU1221951129.SGD","LU1506573853.SGD","IE00BN8TJ469.HKD","LU0466842654.USD","LU0345769631.USD","BK4585","LU0820562030.AUD","LU2129689431.USD","LU2430703095.HKD","LU0689626769.HKD","LU1066053197.SGD","LU0545562505.USD","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU1032955483.USD","SG9999001176.SGD","IE0034235303.USD","LU0234570918.USD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU0114720955.EUR","LU1718418525.SGD","BK4533","BK4588","BK4581","LU1629891620.HKD","LU1894683264.USD","LU1674673691.USD","LU2112291526.USD","LU0122379950.USD","LU0210536198.USD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0795875086.SGD","LU0098860793.USD","LU1059921491.USD","LU1228905037.USD","LU1061106388.HKD","LU0289739699.SGD","LU2430703251.USD","LU2456880835.USD","LU2756315664.SGD","IE00B19Z3581.USD","LU1244550494.USD","LU1145028129.USD","LU2129689605.HKD","IE00BLSP4452.SGD","LU0345770308.USD","SGXZ57979304.SGD","LU0689472784.USD","LU0985320562.USD","LU0795875169.SGD","LU2417539215.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","BK4534","LU0426412945.USD","LU1074936037.SGD","LU1894683348.USD","LU1023059063.AUD","LU2471134952.CNY","LU2403377893.USD","IE00B42XCP33.USD","LU0787776722.HKD","LU1244550577.SGD","IE00BVYPNW00.USD","IE00B1BXHZ80.USD","LU0345770993.USD","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","LU1929549753.HKD","IE0009355771.USD","LU2487616109.SGD","LU0234572021.USD","LU0320765646.SGD","LU2592432038.USD","LU0994945656.USD","LU2089984988.USD","BK4568","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU1732800096.USD","LU1043141123.HKD","LU2505996681.GBP","LU2471134523.USD","IE00BJT1NW94.SGD","LU2896262040.SGD","IE00BDGV0183.EUR","LU2129689514.USD","LU1244550221.USD","BK4007","IE00B7SZLL34.SGD","LU0203345920.USD","IE0001KFT4U8.USD","IE0002141913.USD","LU1221951046.USD","LU1732799900.SGD","IE0002270589.USD","IE000WAW04H5.SGD","LU0882574055.USD","BK4592","LU0070217475.USD","LU2602419157.SGD","LU2756315318.SGD","IE00B4R5TH58.HKD","LU0345769128.USD","LU0203347892.USD","SG9999001176.USD","LU1914381329.SGD","LU1280957306.USD","LU1674673428.USD","IE00BFXG1179.USD","LU1430594728.SGD","IE0000B7K699.USD","LU1935042991.SGD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641848296","title":"强生(JNJ)将以10亿美元全现金方式收购生物技术公司Firefly 卡位下一代抗体工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2641848296","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641848296?lang=zh_cn&edition=full","pubTime":"2026-06-08 21:04","pubTimestamp":1780923864,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生公司 宣布已达成最终协议，将以10亿美元全现金方式收购新锐生物技术公司Firefly Bio, Inc.。通过此次收购，强生将把Firefly独有的Firelink降解抗体偶联物技术平台收入囊中，旨在攻克靶向泛KRAS及其他难治性实体瘤驱动因素，全面深化其在下一代抗体工程领域的领军地位。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDhjNmU2MGE5ZmU5MzgyMDQ4NDM0MDU5MzkwMTYw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301276","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1066051225.USD","JNJ","LU0124676726.USD","LU1074936037.SGD","LU2430703095.HKD","LU1732799900.SGD","LU2602419157.SGD","LU0203347892.USD","LU0432979614.USD","LU0820562030.AUD","IE0002141913.USD","LU2468319806.SGD","IE000F7OJYX1.SGD","LU1506573853.SGD","LU1935042991.SGD","LU1244550221.USD","BK4007","IE00B42XCP33.USD","BK4592","LU1718418525.SGD","LU0203345920.USD","LU0210536198.USD","LU0689472784.USD","IE000M9KFDE8.USD","LU2023250330.USD","IE00B3PB1722.GBP","IE00BLSP4239.USD","LU0053666078.USD","LU2213496289.HKD","LU1221951046.USD","LU0234570918.USD","LU1221951129.SGD","IE00BSNM7G36.USD","LU1244550494.USD","LU2430703178.SGD","IE00BFXG1179.USD","IE00BLSP4452.SGD","LU2750360641.GBP","IE0000B7K699.USD","LU0994945656.USD","LU0545562505.USD","IE00BVYPNW00.USD","LU0640476718.USD","LU0943347566.SGD","IE000WAW04H5.SGD","LU2430703251.USD","LU2089984988.USD","LU2505996681.GBP","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123944460","title":"强生拟收购Firefly Bio以拓展其肿瘤治疗产品线 引入新型降解抗体偶联平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1123944460","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123944460?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:05","pubTimestamp":1780920336,"startTime":"0","endTime":"0","summary":"强生公司宣布，将收购Firefly Bio公司，旨在通过引入其创新的降解抗体偶联平台，进一步扩展其肿瘤学产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689514.USD","SG9999002232.USD","LU2112291526.USD","LU1585245621.USD","BK4007","LU2471134796.USD","LU2602419157.SGD","LU0234572021.USD","LU1162221912.USD","LU0114720955.EUR","LU1778281490.HKD","IE00BBT3K403.USD","LU1935042991.SGD","LU1894683348.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0964807845.USD","LU0345769128.USD","BK4550","LU2505996509.AUD","LU0289739699.SGD","IE000SO60NU8.SGD","LU0234570918.USD","LU0432979614.USD","LU1674673428.USD","LU0820561909.HKD","LU2430703095.HKD","LU0058720904.USD","BK4585","LU2750360641.GBP","SG9999002224.SGD","JNJ","LU1228905037.USD","IE0034235303.USD","LU2023250330.USD","IE00BLSP4452.SGD","IE00B42XCP33.USD","LU1496350502.SGD","LU1145028129.USD","LU0122379950.USD","BK4588","LU1551013342.USD","LU2129689605.HKD","LU1059921491.USD","IE00BSNM7G36.USD","LU0345769631.USD","LU1914381329.SGD","LU0203345920.USD","IE00B2B36J28.USD","SG9999001440.SGD","IE00BGHQF631.EUR","LU2347655156.SGD","LU2896262040.SGD","SG9999013999.USD","LU1221951129.SGD","LU2430703178.SGD","LU0124676726.USD","LU0345770308.USD","LU1929549753.HKD","LU1732799900.SGD","LU2213496289.HKD","IE00B4R5TH58.HKD","LU2430703251.USD","IE00BFTCPJ56.SGD","LU2592432038.USD","LU2417539215.USD","LU2456880835.USD","IE0002270589.USD","LU1023059063.AUD","LU1121112475.USD","IE000MB6IJN5.SGD","IE00BDGV0183.EUR","LU0689472784.USD","LU1430594728.SGD","LU1732800096.USD","LU0792757196.USD","BK4532","BK4534","LU1674673691.USD","LU0210528500.USD","LU1057294990.SGD","LU2403377893.USD","IE0000B7K699.USD","IE00B7SZLL34.SGD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU2750360997.AUD","LU1629891620.HKD","IE00B3T34201.USD","LU1032466523.USD","LU1244550221.USD","LU0689626769.HKD","LU0994945656.USD","IE00BVYPNW00.USD","IE000F7OJYX1.SGD","LU0683600562.USD","LU1894683264.USD","LU0882574055.USD","LU0053666078.USD","LU0795875169.SGD","IE000BZT7R73.USD","LU2471134879.HKD","LU2089984988.USD","LU0820561818.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","LU1506573853.SGD","IE00BJT1NW94.SGD","LU0795875086.SGD","LU2756315318.SGD","LU1267930813.SGD","IE000M9KFDE8.USD","LU1718418525.SGD","LU0985320562.USD","LU1280957306.USD","LU2471134523.USD","LU0098860793.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE0002141913.USD","LU1244550577.SGD","LU0426412945.USD","LU1261432733.SGD","LU2236285917.USD","IE00BZ1G4Q59.USD","LU2471134952.CNY","LU0787776722.HKD","LU0203347892.USD","LU1061106388.HKD","SG9999001176.USD","LU0426417589.USD","LU0820562030.AUD","LU1983299246.USD","LU2468319806.SGD","LU2487616109.SGD","LU0889566641.SGD","LU1228905540.USD","LU1043141123.HKD","LU1244550494.USD","LU0210536198.USD","BK4568","IE00BN8TJ469.HKD","LU1221951046.USD","BK4533","LU0912757837.SGD","BK4559","LU0070217475.USD","LU1066053197.SGD","IE00B3PB1722.GBP","LU1551013425.SGD","LU1074936037.SGD","LU0345770993.USD","BK4504","IE0009355771.USD","LU2129689431.USD","LU1032955483.USD","LU1196500208.SGD","IE000WAW04H5.SGD","LU1066051498.USD","LU1066051811.HKD","LU1043141396.HKD","BK4581","BK4592","LU1066051225.USD","LU0545562505.USD","IE00B19Z3581.USD","LU0640476718.USD","IE00BFXG1179.USD","LU2133065610.SGD","LU2756315664.SGD","SG9999001176.SGD","LU0943347566.SGD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641212565","title":"强生胜诉 此前有诉讼指控其滑石粉导致三名女性患癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641212565","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641212565?lang=zh_cn&edition=full","pubTime":"2026-06-06 08:57","pubTimestamp":1780707420,"startTime":"0","endTime":"0","summary":"近日，洛杉矶陪审团在一桩由三名女性家属提起的诉讼中支持强生公司，这些家属指控该公司的滑石粉产品导致了卵巢癌。陪审团裁定，强生公司在销售化妆品用滑石粉产品时不存在过失。　　已有超过67000名原告起诉强生公司，指控其婴儿爽身粉及其他滑石粉产品导致卵巢癌。　　强生公司已于2020年停止在美国销售含滑石粉的婴儿爽身粉，转而销售玉米淀粉产品。　　强生公司已就大部分指控其产品导致间皮瘤的案件达成和解。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-06/doc-iniamnzu2195114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0689626769.HKD","IE0009355771.USD","LU2756315664.SGD","LU0210528500.USD","IE00BFXG1179.USD","LU2471134952.CNY","IE000MB6IJN5.SGD","LU2602419157.SGD","LU1894683264.USD","LU1043141396.HKD","LU0203345920.USD","BK4534","LU2456880835.USD","LU0545562505.USD","LU1066051811.HKD","LU1032466523.USD","LU2505996681.GBP","IE00B1BXHZ80.USD","JNJ","LU1228905540.USD","LU0345769128.USD","LU2505996509.AUD","BK4559","LU2896262040.SGD","IE00BVYPNW00.USD","LU0234572021.USD","LU1066051225.USD","LU2236285917.USD","LU0683600562.USD","SGXZ57979304.SGD","BK4504","SG9999002232.USD","LU1145028129.USD","IE00B7SZLL34.SGD","LU1162221912.USD","LU0820561818.USD","LU2129689514.USD","BK4533","LU0124676726.USD","LU0058720904.USD","LU0943347566.SGD","IE00B4R5TH58.HKD","LU0882574055.USD","LU1674673428.USD","LU2129689605.HKD","IE00B2B36J28.USD","LU0203347892.USD","IE00BDGV0183.EUR","LU1914381329.SGD","IE000WAW04H5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141239715","title":"异动解读｜强生盘中上涨3.02%，多项临床数据密集公布提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1141239715","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141239715?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:39","pubTimestamp":1780684749,"startTime":"0","endTime":"0","summary":"6月6日，强生盘中上涨3.02%，报235.01美元/股，成交额9.15亿美元。消息面上，强生近期密集披露多项关键临床数据。其中，Nipocalimab在系统性红斑狼疮二期研究中达到主要终点，24周时显著降低疾病活动度，并在自身抗体高活性干燥综合征患者中实现62.5%应答率。多条管线数据集中释放积极信号，为公司研发实力和未来增长预期提供支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641164638","title":"Alvotech再次向FDA提交强生Simponi和再生元Eylea生物类似药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2641164638","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641164638?lang=zh_cn&edition=full","pubTime":"2026-06-05 03:16","pubTimestamp":1780600560,"startTime":"0","endTime":"0","summary":"冰岛生物制药公司Alvotech周四宣布，已再次向美国食品药品监督管理局提交两款生物类似药的生物制剂许可申请，分别针对强生的Simponi和再生元的Eylea。此次提交是与合作伙伴Teva共同推进的，标志着两家公司在拓展美国生物类似药市场方面迈出关键一步。AVT05是强生旗下Simponi及其静脉注射剂型Simponi Aria的生物类似药，该药属于肿瘤坏死因子阻滞剂，用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、溃疡性结肠炎等多种慢性炎症性疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahtfh8923892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1585245621.USD","LU2430703178.SGD","SG9999002232.USD","IE00BLSP4452.SGD","IE000F7OJYX1.SGD","IPOS","LU1074936037.SGD","LU0964807845.USD","LU1261432733.SGD","LU0689626769.HKD","LU1280957306.USD","IE00BJT1NW94.SGD","BK4139","IE00B3PB1722.GBP","LU1629891620.HKD","IE00B19Z3581.USD","LU0053666078.USD","IE00BN8TJ469.HKD","IE000SO60NU8.SGD","LABU","LU0432979614.USD","ALVO","IE00BDGV0183.EUR","JNJ","LU0882574055.USD","SG9999001176.USD","IE00BLSP4239.USD","LU2213496289.HKD","BK4588","LU1551013425.SGD","IE00B3T34201.USD","LU0203345920.USD","BK4007","BK4504","IE00B1BXHZ80.USD","LU1244550577.SGD","LU2417539215.USD","LU0545562505.USD","LU1894683348.USD","LU1032466523.USD","LU1066051225.USD","LU1228905037.USD","BK4592","IE000BZT7R73.USD","LU2750360641.GBP","LU2112291526.USD","LU0683600562.USD","LU1121112475.USD","LU0114720955.EUR","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198299299","title":"强生：Nipocalimab安全性特征与既往研究一致，未发现新安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1198299299","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198299299?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:09","pubTimestamp":1780488594,"startTime":"0","endTime":"0","summary":"强生公司宣布，其药物Nipocalimab的安全性特征与之前对该药物的研究结果保持一致，且未发现新的安全性信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU2471134796.USD","IE000F7OJYX1.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1196500208.SGD","LU1496350502.SGD","LU1261432733.SGD","LU1585245621.USD","LU1228905540.USD","SG9999001440.SGD","LU1057294990.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0889566641.SGD","LU1043141396.HKD","SG9999013999.USD","LU2236285917.USD","LU2347655156.SGD","LU0426417589.USD","LU2213496289.HKD","BK4532","LU0124676726.USD","IE00B2B36J28.USD","LU0683600562.USD","BK4550","LU0820561818.USD","LU0432979614.USD","IE000SO60NU8.SGD","LU2133065610.SGD","LU0053666078.USD","BK4504","LU1066051225.USD","LU0792757196.USD","SG9999002224.SGD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU2430703178.SGD","LU2471134879.HKD","LU2750360641.GBP","BK4559","LU0912757837.SGD","LU1983299246.USD","LU1032466523.USD","LU2468319806.SGD","LU0210528500.USD","LU1066051498.USD","IE00B3T34201.USD","LU1121112475.USD","LU2505996509.AUD","LU1551013425.SGD","IE000BZT7R73.USD","LU2023250330.USD","LU0820561909.HKD","LU1267930813.SGD","LU0964807845.USD","LU1551013342.USD","LU1221951129.SGD","LU1506573853.SGD","IE00BN8TJ469.HKD","LU0466842654.USD","LU0345769631.USD","BK4585","LU0820562030.AUD","LU2129689431.USD","LU2430703095.HKD","LU0689626769.HKD","LU1066053197.SGD","LU0545562505.USD","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU1032955483.USD","SG9999001176.SGD","IE0034235303.USD","LU0234570918.USD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU0114720955.EUR","LU1718418525.SGD","BK4533","BK4588","BK4581","LU1629891620.HKD","LU1894683264.USD","LU1674673691.USD","LU2112291526.USD","LU0122379950.USD","LU0210536198.USD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0795875086.SGD","LU0098860793.USD","LU1059921491.USD","LU1228905037.USD","LU1061106388.HKD","LU0289739699.SGD","LU2430703251.USD","LU2456880835.USD","LU2756315664.SGD","IE00B19Z3581.USD","LU1244550494.USD","LU1145028129.USD","LU2129689605.HKD","IE00BLSP4452.SGD","LU0345770308.USD","SGXZ57979304.SGD","LU0689472784.USD","LU0985320562.USD","LU0795875169.SGD","LU2417539215.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","BK4534","LU0426412945.USD","LU1074936037.SGD","LU1894683348.USD","LU1023059063.AUD","LU2471134952.CNY","LU2403377893.USD","IE00B42XCP33.USD","LU0787776722.HKD","LU1244550577.SGD","IE00BVYPNW00.USD","IE00B1BXHZ80.USD","LU0345770993.USD","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","LU1929549753.HKD","IE0009355771.USD","LU2487616109.SGD","LU0234572021.USD","LU0320765646.SGD","LU2592432038.USD","LU0994945656.USD","LU2089984988.USD","BK4568","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU1732800096.USD","LU1043141123.HKD","LU2505996681.GBP","LU2471134523.USD","IE00BJT1NW94.SGD","LU2896262040.SGD","IE00BDGV0183.EUR","LU2129689514.USD","LU1244550221.USD","BK4007","IE00B7SZLL34.SGD","LU0203345920.USD","IE0001KFT4U8.USD","IE0002141913.USD","LU1221951046.USD","LU1732799900.SGD","IE0002270589.USD","IE000WAW04H5.SGD","LU0882574055.USD","BK4592","LU0070217475.USD","LU2602419157.SGD","LU2756315318.SGD","IE00B4R5TH58.HKD","LU0345769128.USD","LU0203347892.USD","SG9999001176.USD","LU1914381329.SGD","LU1280957306.USD","LU1674673428.USD","IE00BFXG1179.USD","LU1430594728.SGD","IE0000B7K699.USD","LU1935042991.SGD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153181002","title":"强生宣布：Nipocalimab在24周时达到SLE应答指数4评估疾病活动度降低的主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1153181002","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153181002?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:04","pubTimestamp":1780488272,"startTime":"0","endTime":"0","summary":"强生公司宣布，其药物Nipocalimab在关键临床试验中达到了主要终点。数据显示，在治疗24周后，通过系统性红斑狼疮应答指数4进行评估，该药物显著降低了患者的疾病活动度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU1061106388.HKD","LU2403377893.USD","LU2592432038.USD","LU1228905540.USD","LU1983299246.USD","LU1914381329.SGD","BK4568","LU2213496289.HKD","LU2430703251.USD","LU0432979614.USD","LU2129689605.HKD","SG9999001440.SGD","LU2756315664.SGD","IE00B7SZLL34.SGD","LU2456880835.USD","LU1145028129.USD","LU1629891620.HKD","LU1674673428.USD","IE000M9KFDE8.USD","LU2430703095.HKD","JNJ","LU1496350502.SGD","LU2133065610.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0964807845.USD","LU0098860793.USD","BK4532","LU0689626769.HKD","LU0820561818.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1244550494.USD","LU1196500208.SGD","LU0889566641.SGD","SG9999001176.SGD","SG9999001176.USD","BK4550","LU0053666078.USD","LU0345770993.USD","IE00B42XCP33.USD","LU0689472784.USD","LU1228905037.USD","LU1221951046.USD","LU2347655156.SGD","LU1059921491.USD","LU1506573853.SGD","LU0426417589.USD","LU1066053197.SGD","LU0320765646.SGD","IE0000B7K699.USD","BK4585","IE00B3PB1722.GBP","IE00BFTCPJ56.SGD","LU1066051498.USD","LU2505996509.AUD","LU2505996681.GBP","LU0210528500.USD","LU1066051225.USD","LU1929549753.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU0795875169.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0058720904.USD","LU2471134952.CNY","LU2750360997.AUD","LU0345769631.USD","LU1894683348.USD","BK4533","BK4581","IE00BLSP4239.USD","LU1244550221.USD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU1935042991.SGD","IE00BVYPNW00.USD","LU1066051811.HKD","LU1032466523.USD","LU2471134523.USD","LU0787776722.HKD","IE000MB6IJN5.SGD","SG9999002224.SGD","IE00BGHQF631.EUR","LU2430703178.SGD","BK4559","IE0002270589.USD","LU0545562505.USD","LU1032955483.USD","IE00BN8TJ469.HKD","LU0795875086.SGD","LU1221951129.SGD","IE00B4R5TH58.HKD","LU1280957306.USD","IE00BFXG1179.USD","LU2471134879.HKD","LU0994945656.USD","LU1674673691.USD","IE00B3T34201.USD","LU1732799900.SGD","IE00B1BXHZ80.USD","LU1585245621.USD","LU2129689514.USD","IE000BZT7R73.USD","LU0426412945.USD","LU2750360641.GBP","BK4007","IE0009355771.USD","LU1043141396.HKD","IE000F7OJYX1.SGD","LU1267930813.SGD","LU0122379950.USD","LU0683600562.USD","LU2129689431.USD","LU1551013342.USD","IE00BKVL7J92.USD","LU1261432733.SGD","LU1894683264.USD","LU1718418525.SGD","LU0210536198.USD","LU1121112475.USD","BK4504","LU2896262040.SGD","LU2236285917.USD","SGXZ57979304.SGD","LU0124676726.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU0070217475.USD","SG9999013999.USD","LU2471134796.USD","LU0345770308.USD","LU0640476718.USD","IE00BVYPNV92.GBP","LU0289739699.SGD","LU1244550577.SGD","LU2023250330.USD","IE0001KFT4U8.USD","LU1732800096.USD","LU0466842654.USD","LU0234570918.USD","LU0943347566.SGD","LU1778281490.HKD","LU1074936037.SGD","LU1162221912.USD","LU0912757837.SGD","SG9999002232.USD","LU1043141123.HKD","LU0820562030.AUD","LU0792757196.USD","LU2089984988.USD","LU0882574055.USD","IE000WAW04H5.SGD","IE0034235303.USD","LU0203347892.USD","LU0985320562.USD","IE0002141913.USD","IE000SO60NU8.SGD","LU2602419157.SGD","LU0345769128.USD","LU0203345920.USD","LU0820561909.HKD","LU1551013425.SGD","LU2756315318.SGD","BK4534","LU2417539215.USD","BK4588","LU2112291526.USD","BK4592","IE00BBT3K403.USD","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103997126","title":"强生公布系统性红斑狼疮治疗数据：疾病活动度显著降低，疗效持续超过24周主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1103997126","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103997126?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:03","pubTimestamp":1780488214,"startTime":"0","endTime":"0","summary":"强生公司近日公布的研究结果显示，其针对系统性红斑狼疮的治疗方案，在关键临床研究中展现出显著降低疾病活动度的效果。尤为值得关注的是，这一积极疗效在超过预定的24周主要评估终点后，仍得以持续显现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","LU0466842654.USD","LU0943347566.SGD","BK4581","IE00BGHQF631.EUR","LU2602419157.SGD","LU2213496289.HKD","BK4532","LU1032955483.USD","LU2471134879.HKD","LU0889566641.SGD","LU1674673691.USD","LU1506573853.SGD","LU1929549753.HKD","IE00BDGV0183.EUR","IE00BVYPNV92.GBP","IE0002270589.USD","LU1551013425.SGD","IE0001KFT4U8.USD","LU2133065610.SGD","SG9999002224.SGD","LU2750360641.GBP","IE00BLSP4452.SGD","LU2417539215.USD","LU2347655156.SGD","LU0345770308.USD","SG9999013999.USD","LU2430703178.SGD","LU1732799900.SGD","IE0000B7K699.USD","LU2129689514.USD","LU0820561818.USD","IE00B19Z3B42.SGD","LU1718418525.SGD","LU0640476718.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU1057294990.SGD","LU1914381329.SGD","LU1145028129.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","IE000MB6IJN5.SGD","LU1244550577.SGD","LU1732800096.USD","LU0234572021.USD","SG9999002232.USD","LU1585245621.USD","LU1221951129.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU0098860793.USD","LU2505996681.GBP","LU0985320562.USD","IE00BBT3K403.USD","LU1228905037.USD","LU1244550221.USD","LU1267930813.SGD","LU2430703095.HKD","LU2089984988.USD","LU0426412945.USD","LU1032466523.USD","LU1674673428.USD","LU2112291526.USD","LU2236285917.USD","LU2505996509.AUD","LU1121112475.USD","IE0034235303.USD","LU0820562030.AUD","LU0345769631.USD","LU1066051811.HKD","SGXZ57979304.SGD","LU0345769128.USD","IE000F7OJYX1.SGD","IE0009355771.USD","LU0203347892.USD","BK4559","BK4007","LU0683600562.USD","LU2023250330.USD","IE000BZT7R73.USD","BK4550","LU1023059063.AUD","IE000SO60NU8.SGD","LU1196500208.SGD","LU2471134952.CNY","IE00BZ1G4Q59.USD","LU0792757196.USD","LU0545562505.USD","LU0912757837.SGD","LU1066053197.SGD","LU1221951046.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0964807845.USD","LU0210536198.USD","LU0320765646.SGD","LU2129689431.USD","LU0289739699.SGD","IE00BFXG1179.USD","IE00BN8TJ469.HKD","LU0345770993.USD","LU0432979614.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE00BVYPNW00.USD","LU0053666078.USD","IE000M9KFDE8.USD","LU1935042991.SGD","LU2471134523.USD","LU0070217475.USD","LU0114720955.EUR","LU1066051498.USD","LU1280957306.USD","IE00B2B36J28.USD","LU1894683348.USD","LU2592432038.USD","LU2896262040.SGD","LU0689472784.USD","LU2471134796.USD","LU1043141123.HKD","LU2430703251.USD","BK4568","BK4533","SG9999001176.USD","LU0795875169.SGD","BK4585","BK4592","LU1261432733.SGD","LU1061106388.HKD","BK4588","IE00B3T34201.USD","LU0689626769.HKD","LU1066051225.USD","BK4504","LU1074936037.SGD","LU1629891620.HKD","BK4534","LU0203345920.USD","LU2756315664.SGD","LU1043141396.HKD","IE00BFTCPJ56.SGD","LU1244550494.USD","LU2756315318.SGD","JNJ","LU1059921491.USD","LU0122379950.USD","LU2487616109.SGD","LU2750360997.AUD","LU1778281490.HKD","IE00BLSP4239.USD","LU1551013342.USD","IE000WAW04H5.SGD","LU1496350502.SGD","LU2403377893.USD","LU2129689605.HKD","LU0820561909.HKD","LU1430594728.SGD","LU0124676726.USD","LU0426417589.USD","LU0882574055.USD","LU1162221912.USD","IE0002141913.USD","LU0787776722.HKD","LU1894683264.USD","LU0795875086.SGD","IE00B42XCP33.USD","IE00B3PB1722.GBP","IE00B1BXHZ80.USD","LU0994945656.USD","LU1228905540.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134771546","title":"强生Dahlias二期研究显示：Nipocalimab在自身抗体高活性干燥综合征患者中实现62.5%应答率","url":"https://stock-news.laohu8.com/highlight/detail?id=1134771546","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134771546?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:55","pubTimestamp":1780487718,"startTime":"0","endTime":"0","summary":"强生公司近日公布了一项名为Dahlias的二期临床研究结果。数据显示，其研究药物Nipocalimab在治疗自身抗体高活性的干燥综合征患者时，取得了62.5%的应答率。这项积极成果为后续临床开发提供了重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2403377893.USD","LU2112291526.USD","IE000M9KFDE8.USD","LU1267930813.SGD","LU1496350502.SGD","IE00BN8TJ469.HKD","SG9999001440.SGD","LU0114720955.EUR","IE000BZT7R73.USD","BK4592","IE00B19Z3B42.SGD","SG9999002232.USD","BK4568","LU1066051811.HKD","LU2430703251.USD","LU0792757196.USD","BK4534","LU2430703095.HKD","LU2133065610.SGD","LU0070217475.USD","LU1228905037.USD","LU2487616109.SGD","LU1551013342.USD","LU0234572021.USD","LU1032466523.USD","LU1244550494.USD","IE00BLSP4452.SGD","LU2417539215.USD","LU2236285917.USD","LU0683600562.USD","IE00B19Z3581.USD","IE0000B7K699.USD","BK4581","IE0009355771.USD","LU1732800096.USD","LU1935042991.SGD","LU0689472784.USD","IE000SO60NU8.SGD","IE0001KFT4U8.USD","SG9999001176.USD","LU2023250330.USD","BK4585","BK4550","BK4559","LU1914381329.SGD","LU0345770993.USD","LU0203347892.USD","LU0426412945.USD","BK4007","LU0345769128.USD","LU0124676726.USD","LU1059921491.USD","LU0210536198.USD","IE00BZ1G4Q59.USD","LU0943347566.SGD","LU1145028129.USD","LU2471134879.HKD","LU2129689514.USD","LU2592432038.USD","LU1057294990.SGD","BK4588","IE000F7OJYX1.SGD","LU1894683264.USD","LU0994945656.USD","LU2089984988.USD","SG9999013999.USD","LU2602419157.SGD","LU1244550577.SGD","IE00BVYPNW00.USD","LU0985320562.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU0912757837.SGD","LU0795875169.SGD","LU0432979614.USD","LU2750360997.AUD","LU2456880835.USD","LU1066051225.USD","IE00B2B36J28.USD","LU1261432733.SGD","LU1983299246.USD","SG9999002224.SGD","LU0820561909.HKD","LU2505996509.AUD","IE00B3T34201.USD","LU1280957306.USD","IE00B4R5TH58.HKD","LU2505996681.GBP","LU1674673428.USD","LU2347655156.SGD","IE00BFXG1179.USD","LU1043141396.HKD","LU2430703178.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","IE00B3PB1722.GBP","LU2468319806.SGD","LU0820562030.AUD","IE00BKVL7J92.USD","IE000WAW04H5.SGD","LU1221951129.SGD","LU0426417589.USD","IE00BJT1NW94.SGD","IE00BVYPNV92.GBP","LU2129689605.HKD","LU0210528500.USD","LU0689626769.HKD","JNJ","LU1043141123.HKD","LU0964807845.USD","IE0034235303.USD","LU1196500208.SGD","IE00BSNM7G36.USD","IE00BDGV0183.EUR","LU0795875086.SGD","LU2756315664.SGD","LU0234570918.USD","IE000MB6IJN5.SGD","IE00BLSP4239.USD","LU1629891620.HKD","LU0345770308.USD","LU1032955483.USD","LU0320765646.SGD","BK4504","LU1778281490.HKD","LU1061106388.HKD","LU2129689431.USD","IE00B42XCP33.USD","LU1121112475.USD","IE0002141913.USD","LU1929549753.HKD","LU1430594728.SGD","LU2471134796.USD","LU0053666078.USD","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU0345769631.USD","BK4532","LU2471134523.USD","LU1718418525.SGD","LU1244550221.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU2896262040.SGD","LU1066051498.USD","LU0882574055.USD","LU1732799900.SGD","IE00B1BXHZ80.USD","LU0545562505.USD","LU1228905540.USD","SGXZ57979304.SGD","LU0098860793.USD","LU1162221912.USD","LU1074936037.SGD","LU0289739699.SGD","LU2213496289.HKD","LU0122379950.USD","LU2750360641.GBP","LU0787776722.HKD","LU1551013425.SGD","LU1674673691.USD","BK4533","LU1023059063.AUD","LU1506573853.SGD","LU0889566641.SGD","LU2471134952.CNY","LU0820561818.USD","LU1221951046.USD","LU2756315318.SGD","LU1585245621.USD","LU1894683348.USD","LU0640476718.USD","LU0466842654.USD","LU0203345920.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119152804","title":"强生公布新数据，进一步证实尼泊卡单抗在降低驱动干燥综合征的自身抗体方面的作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1119152804","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119152804?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:53","pubTimestamp":1780487596,"startTime":"0","endTime":"0","summary":"强生公司近日公布了新的研究数据，这些数据进一步巩固了尼泊卡单抗在减少导致干燥综合征的自身体抗体方面的关键作用。新发现为这种潜在的治疗方案提供了更坚实的科学依据，凸显了其在应对这一自身免疫性疾病中的重要性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032955483.USD","LU1894683264.USD","LU0787776722.HKD","LU1066053197.SGD","LU1244550221.USD","SG9999002232.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","IE0002270589.USD","LU1551013425.SGD","LU0234570918.USD","LU2602419157.SGD","LU1121112475.USD","BK4504","LU2471134796.USD","LU0795875169.SGD","LU1496350502.SGD","IE000M9KFDE8.USD","LU2471134952.CNY","LU1221951046.USD","LU1718418525.SGD","LU0882574055.USD","IE00B2B36J28.USD","LU0432979614.USD","LU1061106388.HKD","IE00BFXG1179.USD","LU1551013342.USD","LU1267930813.SGD","IE0034235303.USD","LU0689626769.HKD","LU2023250330.USD","LU0122379950.USD","LU0058720904.USD","LU1228905540.USD","LU1506573853.SGD","BK4007","IE00BKVL7J92.USD","LU0912757837.SGD","LU0203345920.USD","LU0114720955.EUR","LU1043141396.HKD","LU2896262040.SGD","LU1162221912.USD","LU1221951129.SGD","LU0820561818.USD","LU0203347892.USD","LU0320765646.SGD","LU0943347566.SGD","LU2236285917.USD","IE000F7OJYX1.SGD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0210536198.USD","IE00BLSP4452.SGD","LU2129689514.USD","LU2089984988.USD","SG9999013999.USD","LU2468319806.SGD","LU2756315318.SGD","LU1894683348.USD","LU1914381329.SGD","LU0210528500.USD","SG9999001176.SGD","BK4581","IE00BN8TJ469.HKD","LU0683600562.USD","LU1023059063.AUD","LU2112291526.USD","LU1732800096.USD","BK4592","LU0792757196.USD","LU2505996681.GBP","LU1430594728.SGD","IE000BZT7R73.USD","BK4533","LU2592432038.USD","IE00B3T34201.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2213496289.HKD","JNJ","LU1935042991.SGD","IE00B7SZLL34.SGD","LU0426412945.USD","IE000SO60NU8.SGD","LU0070217475.USD","BK4534","SGXZ57979304.SGD","LU2430703178.SGD","IE00BDGV0183.EUR","LU0345769631.USD","LU0820562030.AUD","LU1674673691.USD","LU0795875086.SGD","IE00BBT3K403.USD","LU1732799900.SGD","BK4532","LU1043141123.HKD","LU1983299246.USD","LU2471134523.USD","LU0345770308.USD","LU0124676726.USD","LU0640476718.USD","LU2456880835.USD","LU0985320562.USD","LU0234572021.USD","LU0820561909.HKD","LU1280957306.USD","IE00BGHQF631.EUR","BK4550","LU2505996509.AUD","IE00B3PB1722.GBP","LU2430703095.HKD","LU2750360641.GBP","LU1929549753.HKD","SG9999001176.USD","LU2129689605.HKD","LU0964807845.USD","LU1778281490.HKD","LU1629891620.HKD","IE00BSNM7G36.USD","LU2430703251.USD","SG9999001440.SGD","IE0000B7K699.USD","LU2129689431.USD","LU2487616109.SGD","LU2403377893.USD","LU2347655156.SGD","LU1196500208.SGD","BK4585","IE00BVYPNW00.USD","LU1674673428.USD","IE000WAW04H5.SGD","LU2756315664.SGD","LU0466842654.USD","LU0053666078.USD","LU1066051225.USD","LU1228905037.USD","IE00BLSP4239.USD","BK4568","LU2133065610.SGD","LU1059921491.USD","LU0545562505.USD","IE00B19Z3B42.SGD","LU0889566641.SGD","LU0994945656.USD","LU1032466523.USD","LU1244550494.USD","LU0426417589.USD","SG9999002224.SGD","BK4559","LU2750360997.AUD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU0345769128.USD","LU0689472784.USD","LU1074936037.SGD","IE00B42XCP33.USD","IE00BJJMRZ35.SGD","LU1244550577.SGD","LU1585245621.USD","IE000MB6IJN5.SGD","IE00BVYPNV92.GBP","LU0098860793.USD","LU2417539215.USD","LU1066051811.HKD","BK4588","LU1261432733.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","LU2471134879.HKD","LU0345770993.USD","LU1145028129.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113983849","title":"Rybrevant Faspro™关键数据公布：在治疗选择有限的晚期头颈癌中展现强劲且持久的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1113983849","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113983849?lang=zh_cn&edition=full","pubTime":"2026-05-31 20:31","pubTimestamp":1780230674,"startTime":"0","endTime":"0","summary":"Rybrevant Faspro™（Amivantamab 与 Hyaluronidase-Lpuj 复方制剂）的关键临床试验数据表明，该药物在治疗选择仍然有限的晚期头颈癌患者中，能够产生强劲且持久的治疗应答。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU1894683264.USD","SG9999002224.SGD","LU0545562505.USD","BK4592","IE0009355771.USD","SG9999002232.USD","LU0210536198.USD","LU0124676726.USD","LU0964807845.USD","LU1043141396.HKD","LU2756315664.SGD","LU0203347892.USD","LU2133065610.SGD","LU1043141123.HKD","LU2430703178.SGD","LU2213496289.HKD","SG9999001440.SGD","IE000SO60NU8.SGD","LU2505996509.AUD","LU2602419157.SGD","LU0820562030.AUD","LU1894683348.USD","IE00BFTCPJ56.SGD","LU2403377893.USD","LU1280957306.USD","LU0820561818.USD","LU0985320562.USD","LU0820561909.HKD","IE00BDGV0183.EUR","LU0234570918.USD","IE0002270589.USD","LU2129689431.USD","LU1221951129.SGD","LU0689472784.USD","LU0889566641.SGD","LU2471134796.USD","IE000F7OJYX1.SGD","LU1732800096.USD","LU2456880835.USD","LU0345769128.USD","LU1145028129.USD","LU1267930813.SGD","LU1929549753.HKD","LU0053666078.USD","BK4588","LU1674673691.USD","BK4559","BK4550","LU0098860793.USD","LU2505996681.GBP","LU1066051225.USD","LU1496350502.SGD","IE00B3PB1722.GBP","SG9999001176.SGD","SG9999013999.USD","LU1718418525.SGD","LU0426412945.USD","LU0994945656.USD","LU0320765646.SGD","LU2089984988.USD","LU1732799900.SGD","LU1983299246.USD","LU2430703251.USD","LU1506573853.SGD","LU1674673428.USD","LU1551013342.USD","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU0787776722.HKD","LU0943347566.SGD","LU1244550577.SGD","LU1228905037.USD","LU0689626769.HKD","IE00BLSP4239.USD","LU0058720904.USD","LU0345769631.USD","LU2430703095.HKD","LU1066051811.HKD","BK4534","IE00BVYPNV92.GBP","LU0432979614.USD","LU1023059063.AUD","IE000WAW04H5.SGD","LU1121112475.USD","LU1261432733.SGD","LU0345770993.USD","LU0234572021.USD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU1162221912.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU1221951046.USD","SG9999001176.USD","LU1228905540.USD","LU1935042991.SGD","IE0000B7K699.USD","LU1057294990.SGD","BK4007","IE0034235303.USD","LU0345770308.USD","IE00B3T34201.USD","IE00B1BXHZ80.USD","LU1074936037.SGD","LU2129689514.USD","IE00BSNM7G36.USD","LU1066053197.SGD","LU1244550221.USD","LU0466842654.USD","IE00BFXG1179.USD","JNJ","LU2592432038.USD","LU2236285917.USD","LU1196500208.SGD","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU2023250330.USD","IE00BKVL7J92.USD","LU2756315318.SGD","LU0795875169.SGD","LU0795875086.SGD","IE000M9KFDE8.USD","LU1914381329.SGD","LU1032955483.USD","LU1585245621.USD","LU2347655156.SGD","BK4504","IE00BZ1G4Q59.USD","LU0792757196.USD","LU2487616109.SGD","LU2750360641.GBP","BK4568","LU1244550494.USD","LU0683600562.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU2417539215.USD","LU1778281490.HKD","IE0001KFT4U8.USD","LU2471134879.HKD","LU2112291526.USD","IE00BVYPNW00.USD","BK4585","IE000MB6IJN5.SGD","LU0122379950.USD","LU2129689605.HKD","LU0426417589.USD","SGXZ57979304.SGD","LU1066051498.USD","IE0002141913.USD","BK4533","IE00B7SZLL34.SGD","LU0882574055.USD","LU1061106388.HKD","LU1551013425.SGD","LU2896262040.SGD","IE00B19Z3581.USD","LU0070217475.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU0114720955.EUR","BK4532","LU1430594728.SGD","LU0210528500.USD","IE000BZT7R73.USD","LU0289739699.SGD","LU0912757837.SGD","BK4581","IE00B19Z3B42.SGD","LU2471134952.CNY","LU1059921491.USD","IE00BBT3K403.USD","LU1032466523.USD","LU2471134523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104610498","title":"Rybrevant®（Amivantamab-Vmjw）联合Lazcluze®（Lazertinib）作为一线疗法，在非典型EGFR突变非小细胞肺癌中展现持久临床获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1104610498","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104610498?lang=zh_cn&edition=full","pubTime":"2026-05-30 02:01","pubTimestamp":1780077680,"startTime":"0","endTime":"0","summary":"Rybrevant®（Amivantamab-Vmjw）与Lazcluze®（Lazertinib）联合用药方案，作为非典型EGFR突变非小细胞肺癌的一线治疗，已证实能够带来持久的临床获益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU2756315664.SGD","IE00B2B36J28.USD","SG9999001176.USD","LU1221951046.USD","IE00BVYPNV92.GBP","LU1221951129.SGD","LU0053666078.USD","LU0070217475.USD","LU1162221912.USD","LU2602419157.SGD","LU2430703251.USD","LU0320765646.SGD","LU0882574055.USD","LU1032466523.USD","LU2347655156.SGD","LU1674673428.USD","LU0640476718.USD","LU2471134879.HKD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","LU2023250330.USD","BK4550","LU2417539215.USD","BK4588","LU0820561818.USD","BK4007","IE000MB6IJN5.SGD","LU2112291526.USD","IE00BKVL7J92.USD","LU2750360997.AUD","IE00B3T34201.USD","LU1244550577.SGD","LU2896262040.SGD","LU2750360641.GBP","LU1244550494.USD","LU0787776722.HKD","LU0426417589.USD","LU1032955483.USD","SG9999002224.SGD","LU0820562030.AUD","LU0820561909.HKD","LU1280957306.USD","LU0795875086.SGD","LU1244550221.USD","LU2430703095.HKD","LU0683600562.USD","IE00BZ1G4Q59.USD","LU1732799900.SGD","LU0994945656.USD","LU2505996509.AUD","SG9999013999.USD","LU1551013342.USD","LU1585245621.USD","LU0432979614.USD","IE00B3PB1722.GBP","LU2756315318.SGD","LU1496350502.SGD","SGXZ57979304.SGD","LU0985320562.USD","IE00BDGV0183.EUR","LU1506573853.SGD","SG9999001440.SGD","LU1430594728.SGD","LU1935042991.SGD","LU0889566641.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU2471134952.CNY","LU0122379950.USD","LU0345769631.USD","IE00B19Z3581.USD","LU1066051811.HKD","LU1674673691.USD","LU0689626769.HKD","LU2430703178.SGD","BK4534","BK4585","LU0210536198.USD","LU2089984988.USD","LU0466842654.USD","LU0426412945.USD","BK4533","LU0289739699.SGD","LU1057294990.SGD","LU1074936037.SGD","IE00B1BXHZ80.USD","BK4532","LU1983299246.USD","LU0098860793.USD","BK4568","IE00BJJMRZ35.SGD","IE00BVYPNW00.USD","LU2505996681.GBP","IE0002141913.USD","LU0545562505.USD","LU1043141123.HKD","LU0345769128.USD","LU2213496289.HKD","LU2471134796.USD","LU0792757196.USD","SG9999001176.SGD","LU1732800096.USD","IE0034235303.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU1929549753.HKD","LU0689472784.USD","LU1023059063.AUD","LU1043141396.HKD","IE000F7OJYX1.SGD","LU1718418525.SGD","IE00BBT3K403.USD","IE00BJT1NW94.SGD","LU0203345920.USD","LU1228905540.USD","BK4559","LU1059921491.USD","LU1066051225.USD","LU0345770308.USD","LU2133065610.SGD","LU2456880835.USD","IE0001KFT4U8.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU0058720904.USD","IE00BLSP4239.USD","LU1914381329.SGD","LU1778281490.HKD","LU1629891620.HKD","LU1228905037.USD","IE00BFXG1179.USD","JNJ","BK4592","BK4504","LU1261432733.SGD","IE000M9KFDE8.USD","LU1551013425.SGD","LU0234570918.USD","LU0345770993.USD","LU2403377893.USD","IE00BGHQF631.EUR","LU1894683264.USD","LU2129689431.USD","LU2129689514.USD","IE00BN8TJ469.HKD","LU1894683348.USD","LU2468319806.SGD","LU1066051498.USD","IE000BZT7R73.USD","LU0964807845.USD","LU1121112475.USD","BK4581","IE00B4R5TH58.HKD","IE0000B7K699.USD","LU1145028129.USD","LU1267930813.SGD","LU0203347892.USD","IE00B42XCP33.USD","LU2236285917.USD","LU2487616109.SGD","LU2592432038.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU0234572021.USD","LU0912757837.SGD","LU0943347566.SGD","LU2471134523.USD","LU0210528500.USD","LU2129689605.HKD","SG9999002232.USD","LU0795875169.SGD","LU1196500208.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com;www.investor.jnj.com;www.factsabouttalc.com","stockEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":0.0374},{"period":"3month","weight":-0.0089},{"period":"6month","weight":0.129},{"period":"1year","weight":0.5151},{"period":"ytd","weight":0.1364}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立，是医疗保健领域的全球领先企业。该公司专注于研究、开发、制造、销售种类丰富的医疗保健产品，强调人类的健康和福祉。强生通过两个主要业务部门运营：创新药物和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.543478,"avgChangeRate":0.00367},{"month":2,"riseRate":0.521739,"avgChangeRate":-0.001555},{"month":3,"riseRate":0.586957,"avgChangeRate":0.015928},{"month":4,"riseRate":0.617021,"avgChangeRate":0.030422},{"month":5,"riseRate":0.468085,"avgChangeRate":-0.025771},{"month":6,"riseRate":0.510638,"avgChangeRate":0.006426},{"month":7,"riseRate":0.608696,"avgChangeRate":0.013965},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.01226}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}